Jeong, Hwan-Jeong
(Department of Nuclear Medicine, Chonbuk National University Medical School)
Lim, Seok-Tae (Department of Nuclear Medicine, Chonbuk National University Medical School) Youn, Hyun-Jo (Department of Surgery, Chonbuk National University Medical School) Sohn, Myung-Hee (Department of Nuclear Medicine, Chonbuk National University Medical School) |
1 | Sosa JA, Udelsman R. Total thyroidectomy for differentiated thyroid cancer. J Surg Oncol 2006;94:701-7 DOI ScienceOn |
2 | Bachelot A, Cailleux AF, Klain M, Baudin E, Ricard M, Bellon N, et al. Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma. Thyoid 2002;12:707-11 |
3 | Lee J, Yun JS, Nam KH, Chung WY, Soh EY, Park CS. Papillary mocrocarcinoma: clinicopathologic characteristics and treatment strategy. J Korean Surg Soc 2007;72:276-82 |
4 | Gerard SK, Cavalieri RR. I-123 diagnostic thyroid tumor whole-body scanning with imaging at 6, 24, and 48 hours. Clin Nucl Med 2002;27:1-8 DOI ScienceOn |
5 | Handkiewicz-Junak D, Wloch J, Roskosz J, Krajewska J Kropinska A, Pomorski L, et al. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer. J Nucl Med 2007;48:879-88 DOI |
6 | Mandel SJ, Shankar LK, Benard F, Yamamoto A, Alavi A. Superority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer. Clin Nucl Med 2001;26:6-9 DOI ScienceOn |
7 | Hong SW. Radioiodine therapy for differentiated thyroid cancer. Korean J Nucl Med 2000;34:265-75 과학기술학회마을 |
8 | Kjellman P, Zedenius J, Lundell G, Backdahl M, Farnebo LO, Hamberger B, et al. Predictors of outcome in patients with papillary thyroid carcinoma. Eur J Surg Oncol 2006;32:345-52 DOI ScienceOn |
9 | Cohen JB, Kalinyak JE, McDougall IR. Clinical implications of the differences between diagnostic I-123 and post-therapy I-131 scans. Nucl Med Commun 2004;25:129-34 DOI ScienceOn |
10 | Lang BH, Lo CY, Chan WF, Lam KY, Wan KY. Staging systems for papillary thyroid carcinoma: a review and comparison. Ann Surg 2007;245:366-78 DOI ScienceOn |
11 | Doi SA, Woodhouse NJ. Ablation of the thyroid remnant and I-131 dose in differentiated thyroid cancer. Clin Endocrinol(Oxf) 2000;52:765-73 DOI ScienceOn |
12 | Van Nostrand D, Wartofsky L. Radioiodine in the treatment of thyroid cancer. Endocrinol Metab Clin North Am 2007;36: 807-22 DOI ScienceOn |
13 | Lee SJ, Park BS, Kim JS, Park JS. Analyses of cervical lymph node metastases from papillary thyroid cancer. J Korean Surg Soc 2003;64:115-20 |
14 | Makarewicz J, Adamczewski Z, Knapska-Kucharska M, Lewinski A. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery. Exp Clin Endocrinol Diabetes 2006;114: 485-9 DOI ScienceOn |
15 | Pelizzo MR, Boschin IM, Toniato A, Piotto A, Pagetta C, Gross MD, et al. Papillary thyroid carcinoma: 35-year outcome and prognostic factors in 1858 patients. Clin Nucl Med 2007;32: 440-4 DOI ScienceOn |
16 | Song SH, Park HK, Park YH, Lee JN, Kim JH, Lee YD. Tc-99m tetrofosmin, I-131 whole body scan and thyroglobulin in detecting differentiated thyroid carcinoma metastases. J Korean Surg Soc 2002;63:366-71 |
17 | Urhan M, Dadparvar S, Mavi A, Houseni M, Chamroonrat W, Alavi A, et al. Iodine-123 as a diagnostic agent in differentiated thyroid carcinoma: a comparison with iodine-131 post-treatment scanning and serum thyroglobulin measurement. Eur J Nucl Med Mol Imaging 2007;34:1012-7 DOI |
18 | Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, et al. AJCC cancer staging manual. 6th ed. New York: Springer; 2002. p. 77-87 |
19 | Kim KS, Ryu JS, Hong SJ, Kim WB, Shong YK. Serum thyroglobulin levels predicting recurrence and distant metastasis after surgery in patients with differentiated thyroid cancer. J Kor Soc Endocrinol 2003;18:153-65 |
20 | Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics 2004. Cancer J Clin 2004;54:8-29 DOI ScienceOn |
21 | Ali N, Sebastian C, Foley RR, Murray I, Canizales AL, Jenkins PJ, et al. The management of differentiated thyroid cancer using I-123 for imaging to assess the need for I-131 therapy. Nucl Med Commun 2006;27:165-9 DOI ScienceOn |
22 | Grunwald F, Menzel C, Fimmers R, Zamora PO, Biersack HJ. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer. J Nucl Med 1996;37:1962-4 |
23 | Shong YK. Treatment of differentiated thyroid cancer. Korean J Nucl Med 2002;36:77-97 |
![]() |